Karolinska Institutet | News, Hiring, Layoffs, Competitors, CEO, Fundraising Insights
Karolinska Institutet is one of Europe's largest medical universities, known for its extensive range of medical education and significant...
Karolinska Institutet is one of Europe's largest medical universities, known for its extensive range of medical education and significant contribution to medical academic research. KI Innovations AB, a subsidiary, focuses on transforming research innovations into commercial products and services to create societal value.
Website
Headquarters
Solna, Stockholm County
Size
11-50 employees
Industry
Research
Specialities
Innovation, uppfinning, forskning, affärscoaching, Life Science
🛍️ Karolinska Institutet Product and Pricing News →
👔 Karolinska Institutet CEO, Management and Leadership Team →
⚔️ Karolinska Institutet Alternatives and Competitors →
💼 Karolinska Institutet Hiring and Layoffs →
🤖 Karolinska Institutet Developer, Integration and Automation News →
📈 Karolinska Institutet Financials, Fundraising and Valuation News →
🛍️ Karolinska Institutet Product and Pricing News
- Karolinska Institutet has launched a new initiative as announced on November 20, 2024.
- Karolinska Institutet's Sequrna has launched a thermostable RNAase-inhibitor now available through Genovis.
- Researchers at Karolinska Institutet discovered a molecule that aids gut healing and removes tumor growth in colorectal cancer, potentially leading to new treatments for IBD and cancer.
- Scientists from Karolinska Institutet, Emory University, and the University of Oxford miniaturized a TR-FRET assay to study the SYK and FCER1G interaction in a 1536-well ultra-high throughput screening format.
- Karolinska Institutet is advancing neuroscience research by exploring self-supervised learning methods and developing AI solutions to enhance brain imaging techniques.
- Karolinska Institutet is hosting a networking event at Biomedicum on November 26 to explore their core facilities and connect researchers.
- Dr. J-Matthias Löhr from Karolinska Institutet led new research on using liquid biopsy to diagnose pancreatic incidentaloma, potentially indicating early-stage pancreatic cancer.
- Karolinska Institutet researchers have developed a new method to read cellular information faster and more accurately.
👔 Karolinska Institutet CEO, Management and Leadership Team
⚔️ Karolinska Institutet Alternatives and Competitors
- Imperial College London |
- Erasmus University Rotterdam |
- Mayo Clinic
💼 Karolinska Institutet Hiring and Layoffs
- Johan Weigelt, CEO of Karolinska Institutet Holding AB, announced a new opportunity to find and test entrepreneurs for startups and innovation cases.
- Martin Sundström Rehal is affiliated with the Division of Anaesthesia and Intensive Care at Karolinska Institutet.
- Karolinska Institutet is offering 22 postdoctoral scholarships in various fields including tumor biology, physiology, pharmacology, and biostatistics, with application deadlines in November and December 2024.
🤖 Karolinska Institutet Developer, Integration and Automation News
- Karolinska Institutet is collaborating with the University of Oviedo and the University of Nicosia to offer an Erasmus Mundus Master's in Public Health in Disasters.
- Karolinska Institutet is collaborating with the University of Michigan on a project to translate physics-informed imaging tools into aortic dissection care, involving Dr. Marlevi and Prof. Hultgren from Karolinska Institutet and Prof. Nordsletten from the University of Michigan.
- Karolinska Institutet's holding company, KI Innovations AB, announced a collaboration with FUHS and SEB to launch an innovation scholarship program for recent graduates.
- Karolinska Institutet, in collaboration with MSF and HI UK, has developed the Activity Independence Measure-Trauma course for healthcare professionals in crisis-affected areas.
- Karolinska Institutet has partnered with Inify Laboratories to enhance AI-driven prostate cancer diagnosis through image analysis.
📈 Karolinska Institutet Financials, Fundraising and Valuation News
- Karolinska Institutet has allocated funding to interdisciplinary research projects focused on pressing healthcare challenges, emphasizing innovation through collaborations across scientific and clinical disciplines.
- Intelligyn, a company incubated by KI Innovations AB, secured additional funding from Cancerfonden to support clinical trials at Södersjukhuset for their AI solution in women's healthcare.
- Karolinska Institutet's portfolio company Countagen received funding from Vinnova to develop a diagnostic kit for acute myeloid leukemia using their GeneAbacus technology.